Signaling pathways bridging microbial-triggered inflammation and cancer.
about
Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis?Microbiota impact on the epigenetic regulation of colorectal cancerImmune responses to Helicobacter pylori infection.Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention.CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway.Toll-like receptors and cancer, particularly oral squamous cell carcinoma.Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersIn Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.Metabolome of human gut microbiome is predictive of host dysbiosisExtracted Triterpenes from Antrodia cinnamomea Reduce the Inflammation to Promote the Wound Healing via the STZ Inducing Hyperglycemia-Diabetes Mice Model.Signaling cascades of Pasteurella multocida toxin in immune evasion.The many lives of CTIP2: from AIDS to cancer and cardiac hypertrophy.Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer.Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis.A simple feature construction method for predicting upstream/downstream signal flow in human protein-protein interaction networks.Gastrointestinal absorption, antiproliferative and anti-inflammatory effect of the major carotenoids of Gardenia jasminoides Ellis on cancer cells.Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways.The oral cavity microbiota: between health, oral disease, and cancers of the aerodigestive tract.Could the PI3K canonical pathway be a common link between chronic inflammatory conditions and oral carcinogenesis?Microbiota as a mediator of cancer progression and therapy.S-Fms signalobody enhances myeloid cell growth and migration.Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression.Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.In vitro Monocyte IL-6 Secretion Levels Following Stimulation with Autologous Spheroids Derived from Tumour or Benign Mucosa Predict Long-term Survival in Head and Neck Squamous Cell Carcinoma Patients.Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.Screening for host proteins interacting with Escherichia coli O157:H7 EspF using bimolecular fluorescence complementation.Chelidonine inhibits TNF-α-induced inflammation by suppressing the NF-κB pathways in HCT116 cells.Yeast-containing feed additive alters gene expression profiles associated with innate immunity in whole blood of a rodent model.Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systemsIncreased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses
P2860
Q26770029-ED0B9444-E785-4B59-8FAA-0EBA7F3FC855Q27028132-5EDD7F43-9A18-401F-A0A7-25B894CBE6B6Q33626752-87B8A86F-A9E3-4756-A197-1C53B23BA9D2Q33661094-B733A2ED-A2E0-453F-BE01-F1F86DA0AAD7Q33779417-4D109572-DD95-4340-8D10-D28BA20C3999Q34239239-30AA8FBA-2DD8-47FF-8783-BCE20EEA390DQ34425909-369392E7-0354-4760-A3B8-558D45A2F5CEQ34706060-FF8D0D1E-D8DD-4C39-BD67-9DAEC7E27F3CQ35664923-D90C62BD-0EC0-4116-8162-082DDDA3DBDBQ35778932-8271856D-AF26-4835-9569-5C6F3F43408BQ36995699-CC274A9F-3B46-4CF5-BC3D-9DA09278112EQ38142607-496E18AC-8F92-4DB2-A597-27C4D327F0CBQ38152295-0D728218-9E7F-4830-A563-78C6B0932380Q38204893-69EF7331-379E-4539-9ABC-B59E92142314Q38209323-B3146E60-43D3-4898-9DA1-320A945CEC2EQ38384554-F7707BDA-FE31-482F-9D9C-682ABC80889FQ38711395-BBE2AAC2-687A-449E-806A-00F75C289B64Q38725091-2BAF3A2C-E38E-4D0E-B769-327A0B414212Q38751029-F7D30EFD-1251-4385-82F2-782D7EC732CDQ38780033-2C888DE6-2354-4A61-9C8C-9D16EA8B493FQ38935534-5B754EDD-8FB2-407E-9142-2026F90B06E1Q39038580-B9F79457-E28B-4687-B0FF-4915094621D6Q39338015-E6BFF1E9-01B1-4FB8-90DF-28342487908AQ39682144-4008B7B4-5CAD-4844-B255-FE5EEA200E2EQ40413430-826FBCC0-2527-4057-9796-3312BEA721A7Q41175045-CFFB1059-2BF9-4078-8193-890C6E29600BQ47262383-CF370E29-8EA5-493F-BE12-8AD461ECDBD1Q47634278-CCE9145D-9753-40E1-8B3A-7A8E6792AD54Q55026032-5DA47D44-E36C-4C60-AE7F-58BE7821A7ADQ57161742-E7B1C610-5B6F-4721-86CB-CC6AB4533F2EQ58690861-45F74F6A-50BC-47C7-99C1-1633CF00B5C0
P2860
Signaling pathways bridging microbial-triggered inflammation and cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Signaling pathways bridging microbial-triggered inflammation and cancer.
@en
type
label
Signaling pathways bridging microbial-triggered inflammation and cancer.
@en
prefLabel
Signaling pathways bridging microbial-triggered inflammation and cancer.
@en
P2093
P1433
P1476
Signaling pathways bridging microbial-triggered inflammation and cancer
@en
P2093
Armel Hervé Nwabo Kamdje
Elias Nchiwan Nukenine
Lorella Vecchio
Maulilio John Kipanyula
P304
P356
10.1016/J.CELLSIG.2012.10.014
P577
2012-10-30T00:00:00Z